Brookfield Corp’s Zimmer Biomet ZBH Stock Holding History

Brookfield Corp’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-85,585	Closed	-$11.1M	–	777
2023 Q1	$11.1M	Buy	85,585 +55,985	+189%	+$7.03M	0.04%	153
2022 Q4	$3.77M	Sell	29,600 -95,874	-76%	-$11.1M	0.01%	310
2022 Q3	$13.1M	Buy	+125,474	New	+$13.8M	0.05%	130
2022 Q2	–	Sell	-11,204	Closed	-$1.43M	–	764
2022 Q1	$1.43M	Buy	+11,204	New	+$1.35M	0.01%	451
2021 Q4	–	Sell	-14,429	Closed	-$2.05M	–	749
2021 Q3	$2.05M	Buy	+14,429	New	+$2.12M	0.01%	345
2021 Q2	–	Sell	-38,649	Closed	-$6.01M	–	653
2021 Q1	$6.01M	Buy	38,649 +12,329	+47%	+$1.91M	0.03%	153
2020 Q4	$3.94M	Buy	26,320 +539	+2%	+$76.1K	0.02%	193
2020 Q3	$3.41M	Buy	25,781 +15,621	+154%	+$2.04M	0.02%	182
2020 Q2	$1.18M	Buy	+10,160	New	+$1.17M	0.01%	271

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Brookfield Corp's ZBH Position: Q2 2023 in Review

Brookfield Corp sold out of Zimmer Biomet (ZBH) in Q2 2023, closing a stake of 85,585 shares — an estimated $11.1M sold.

Brookfield Corp first reported a position in ZBH in Q2 2020 and held it in 9 quarters. The position peaked at $13.1M in Q3 2022. 1,030 funds tracked by Wall St. Rank hold ZBH as of Q2 2023.

Brookfield Corp reported no remaining Zimmer Biomet position as of Q2 2023 after selling out during the quarter.
Brookfield Corp sold 85,585 Zimmer Biomet shares in Q2 2023, an estimated $11.1M.
Brookfield Corp first reported a position in Zimmer Biomet in Q2 2020 and held it in 9 quarters.
Brookfield Corp's Zimmer Biomet position peaked at $13.1M in Q3 2022.
1,030 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2023.

Based on Brookfield Corp's 13F filing for Q2 2023, filed 14 Aug 2023.